The “Embryonic Stem Cell” Rese

In November 1995, the first embryonic stem cells from non-human primate were reported. It held out the possibility they may one day derived from human. Actually, three years later they were successful. In March 1999, the Wisconsin Alumni Research Foundation (WARF) dispatched the first batch of cells to be used for research by a “non-UW-Madison user” (“Embryonic Stem Cell Information” 2). After six months, the WARF established a non-profit institute, the WiCell Research Institute, to distribute stem cells for research and to conduct basis stem cell science. However, in 2001, due to the political arguments, the WARF needed to implement a resolution supporting research using human embryonic stem cells. They also got a patent number in that year. On August 9th in 2001, president George Bush proclaimed a policy that would permit scientists to use federal funds to study stem lines derived prior to the president’s announcement (“Remarks by the President on Stem Cell Research” 1). This policy is very significant and we’ll discuss it later on this paper. From this time on, many countries such as Israel, Britain, Germany and of course the United States have collected their own successful experiments.

For information about stem cell technology as it applies to various conditions, patient advocacy groups and organizations that fund and support research into different diseases are perhaps the best source of information. Such organizations tend to monitor the broad research landscape and may be among the first to know about opportunities for clinical trials and other experimental treatments.

On the evening of August 9, 2001 President George W. Bush announced to the world his long awaited decision on stem cell research. Deciding the result of over thousands of frozen embryos was certainly quite a hard choice. The benchmark of his decision was to limit research on embryonic stem cell to only existing cell lines- of which he stated there were sixty-four ("Remarks by the President on Stem Cell Research" 1). The President presented his ethical and moral arguments for this controversial decision as well as a plan for continued bioethical analysis of the issues. He attempted to ‘thread the needle’ of a very complex issue: keep the balance between studying on the embryonic stem cells and applying them to certain patients. In making this compromise, the President raised the level of debate among scientists, researchers, patients, and bioethics on various issues.

According Wisconsin-Madison researchers, one of the benefits of human embryonic stem cell technology bring to our society is in the area of “drug discovery” (“Embryonic Stem Cell Information” 2). With the growing purely of the populations of specific cell types, scientists can prove that each of the cells may cause related medical symptoms. If they can specify using each cell types with certain chemicals and measure their response, they will be able to sort out chemicals that can be used to treat the diseases that involve those specific cell types in a short time rather than they test any medicals for each disease. Therefore, ES technology would allow scientists have faster results with fewer tests and less resources.

Some topics in this essay:
Stem Cells”, Cell Research, Cell Information”, University Wisconsin-Madison, James Thomson, Academy Sciences, United Nation, George Bush, stem cell, National Academies, Cell Lines, embryonic stem, cell research, stem cell research, stem cells, embryonic stem cells, embryonic stem cell, human embryonic, human embryonic stem, “embryonic stem, research embryonic, pontifical academy, cell lines, adult stem, stem cell lines,